Treatment News : Treatment for Depression Increases Hep C Adherence

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

April 13, 2011

Treatment for Depression Increases Hep C Adherence

Antidepressants can significantly boost adherence rates in people living with hepatitis C virus (HCV) being treated with interferon, a drug known to cause depression, according to a study presented at the International Conference on Viral Hepatitis 2011.

For the study, experts at Medco Health Solutions, a U.S.-based pharmacy benefit manager, examined prescription files of 3,607 patients who had recently started taking interferon plus another drug, ribavirin, for the treatment of HCV.  Approximately 1,650 of these patients were also being treated for depression.

Those whose prescription records indicated that they had HCV meds available for use at least 80 percent of the time were considered to be adhering to their drug regimens.

The Medco team found that while about 60 percent of all patients in the study adhered to their treatment regimen, this increased to 68.5 percent among patients also taking antidepressants. This increased further, to 77.3 percent, among patients who were being treated for both hepatitis C and HIV.

The duration of HCV therapy-either 24 o 48 weeks-and likelihood of being cured of the infection depends on a number of factors, including whether or not HCV viral load becomes undetectable during the first three months of treatment. While the virus's genotype and a person's genetic makeup play roles in the effectiveness of treatment, so does a person's ability to take his or her prescribed medications exactly as prescribed.

"Depression, whether interferon-induced or a separate co-morbid condition, can sabotage efforts to effectively treat Hepatitis C," said study author David Muzina, MD, of the Medco Neuroscience Therapeutic Resource Center. "All health care professionals, including pharmacists, need to know how to detect depression and work together to support safe, effective and affordable treatments."

Click here to read more about treatment for hepatitis C.

Search: HCV, hepatitis C, interferon, ribavirin, antidepressants, depression, adherence, HIV, Medco


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.